Dominic joined the Miller lab in spring 2016 and began working on the Amyloid beta project, which would earn him co-authorship on a publication in 2021. Dominic also spent time working on a Ganciclovir as a chemotherapy drug targeting DNA polymerase. Upon returning from an REU experience at Utah State Univ, Dominic proposed a collaboration that resulted in co-authorship on another publication on ATPase inhibitors. Dominic graduated from Truman State Univ with a B.S. in Chemistry in May 2019, and went on to attend graduate school at the University of Wisconsin-Madison.